Literature DB >> 22639343

Chromatin modifications associated with diabetes.

Samuel T Keating1, Assam El-Osta.   

Abstract

Accelerated rates of vascular complications are associated with diabetes mellitus. Environmental factors including hyperglycaemia contribute to the progression of diabetic complications. Epidemiological and experimental animal studies identified poor glycaemic control as a major contributor to the development of complications. These studies suggest that early exposure to hyperglycaemia can instigate the development of complications that present later in the progression of the disease, despite improved glycaemic control. Recent experiments reveal a striking commonality associated with gene-activating hyperglycaemic events and chromatin modification. The best characterised to date are associated with the chemical changes of amino-terminal tails of histone H3. Enzymes that write specified histone tail modifications are not well understood in models of hyperglycaemia and metabolic memory as well as human diabetes. The best-characterised enzyme is the lysine specific Set7 methyltransferase. The contribution of Set7 to the aetiology of diabetic complications may extend to other transcriptional events through methylation of non-histone substrates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22639343     DOI: 10.1007/s12265-012-9380-9

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  131 in total

Review 1.  Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.

Authors:  Anton Eberharter; Peter B Becker
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

2.  The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.

Authors:  Francois Fuks; Paul J Hurd; Daniel Wolf; Xinsheng Nan; Adrian P Bird; Tony Kouzarides
Journal:  J Biol Chem       Date:  2002-11-09       Impact factor: 5.157

Review 3.  SET domain proteins modulate chromatin domains in eu- and heterochromatin.

Authors:  T Jenuwein; G Laible; R Dorn; G Reuter
Journal:  Cell Mol Life Sci       Date:  1998-01       Impact factor: 9.261

4.  Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.

Authors:  M Shikano; H Sobajima; H Yoshikawa; T Toba; H Kushimoto; H Katsumata; M Tomita; S Kawashima
Journal:  Nephron       Date:  2000-05       Impact factor: 2.847

5.  Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Authors:  S Dennler; S Itoh; D Vivien; P ten Dijke; S Huet; J M Gauthier
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

6.  Local hypomethylation in atherosclerosis found in rabbit ec-sod gene.

Authors:  M O Laukkanen; S Mannermaa; M O Hiltunen; S Aittomäki; K Airenne; J Jänne; S Ylä-Herttuala
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

7.  Defects in beta-cell function in functional ovarian hyperandrogenism.

Authors:  N M O'Meara; J D Blackman; D A Ehrmann; R B Barnes; J B Jaspan; R L Rosenfield; K S Polonsky
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

8.  DNA hypomethylation and methyltransferase expression in atherosclerotic lesions.

Authors:  Mikko O Hiltunen; Mikko P Turunen; Tomi P Häkkinen; Juha Rutanen; Maria Hedman; Kimmo Mäkinen; Anna-Mari Turunen; Katriina Aalto-Setälä; Seppo Ylä-Herttuala
Journal:  Vasc Med       Date:  2002-02       Impact factor: 3.239

9.  Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling.

Authors:  M A Ihnat; J E Thorpe; C D Kamat; C Szabó; D E Green; L A Warnke; Z Lacza; A Cselenyák; K Ross; S Shakir; L Piconi; R C Kaltreider; A Ceriello
Journal:  Diabetologia       Date:  2007-05-17       Impact factor: 10.122

10.  Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.

Authors:  Anna Syreeni; Assam El-Osta; Carol Forsblom; Niina Sandholm; Maikki Parkkonen; Lise Tarnow; Hans-Henrik Parving; Amy J McKnight; Alexander P Maxwell; Mark E Cooper; Per-Henrik Groop
Journal:  Diabetes       Date:  2011-09-06       Impact factor: 9.461

View more
  13 in total

Review 1.  Transcriptional regulation by the Set7 lysine methyltransferase.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Epigenetics       Date:  2013-03-11       Impact factor: 4.528

Review 2.  Glycemic memories and the epigenetic component of diabetic nephropathy.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

3.  Deep sequencing reveals novel Set7 networks.

Authors:  Samuel T Keating; Mark Ziemann; Jun Okabe; Abdul Waheed Khan; Aneta Balcerczyk; Assam El-Osta
Journal:  Cell Mol Life Sci       Date:  2014-05-30       Impact factor: 9.261

Review 4.  Mitochondrial regulation of diabetic vascular disease: an emerging opportunity.

Authors:  Michael E Widlansky; R Blake Hill
Journal:  Transl Res       Date:  2018-08-04       Impact factor: 7.012

5.  Coordinate changes in histone modifications, mRNA levels, and metabolite profiles in clonal INS-1 832/13 β-cells accompany functional adaptations to lipotoxicity.

Authors:  Siri Malmgren; Peter Spégel; Anders P H Danielsson; Cecilia L Nagorny; Lotta E Andersson; Marloes Dekker Nitert; Martin Ridderstråle; Hindrik Mulder; Charlotte Ling
Journal:  J Biol Chem       Date:  2013-03-08       Impact factor: 5.157

Review 6.  Balancing chromatin remodeling and histone modifications in transcription.

Authors:  Emily Petty; Lorraine Pillus
Journal:  Trends Genet       Date:  2013-07-16       Impact factor: 11.639

7.  Open chromatin profiling in mice livers reveals unique chromatin variations induced by high fat diet.

Authors:  Amy Leung; Brian W Parks; Juan Du; Candi Trac; Ryan Setten; Yin Chen; Kevin Brown; Aldons J Lusis; Rama Natarajan; Dustin E Schones
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

8.  Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells.

Authors:  Chenlin Gao; Guo Chen; Li Liu; Xia Li; Jianhua He; Lan Jiang; Jianhua Zhu; Yong Xu
Journal:  J Diabetes Res       Date:  2013-04-30       Impact factor: 4.011

9.  Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.

Authors:  Elyse Di Marco; Stephen P Gray; Karin Jandeleit-Dahm
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-05       Impact factor: 5.555

Review 10.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.

Authors:  Francesco Paneni; Joshua A Beckman; Mark A Creager; Francesco Cosentino
Journal:  Eur Heart J       Date:  2013-05-02       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.